The Glycan Role in the Glycopeptide Immunogenicity Revealed by Atomistic Simulations and Spectroscopic Experiments on the Multiple Sclerosis Biomarker CSF114(Glc)
Open Access
- 17 March 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 5 (1), srep09200
- https://doi.org/10.1038/srep09200
Abstract
Glycoproteins are often recognized as not-self molecules by antibodies triggering the onset of severe autoimmune diseases such as Multiple Sclerosis (MS). Thus, the development of antigen-mimicking biomarkers represents an attractive strategy for an early diagnosis of the disease. An example is the synthetic glycopeptide CSF114(Glc), which was designed and tested as MS biomarker and whose clinical application was limited by its reduced ability to detect autoantibodies in MS patients. In the attempt to improve the efficacy of CSF114(Glc), we have characterized all the events leading to the final binding of the biomarker to the autoantibody using atomistic simulations, ESR and NMR experiments. The glycosydic moiety plays a primary role in the whole process. In particular, in an environment mimicking that used in the clinical tests the glycopeptide assumes a α-helix structure that is functional for the interaction with the antibody. In this conformation CSF114(Glc) binds the monoclonal antibody mAb8-18C5 similarly to the myelin oligodendrocyte glycoprotein MOG, which is a known MS auto-antigen, thus explaining its diagnostic activity. Our study offers new molecular bases to design more effective biomarkers and provides a most valid protocol to investigate other systems where the environment effect is determinant for the biological activity.This publication has 54 references indexed in Scilit:
- Recognition of Membrane-Bound Fusion-Peptide/MPER Complexes by the HIV-1 Neutralizing 2F5 Antibody: Implications for Anti-2F5 ImmunogenicityPLOS ONE, 2012
- Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic DiseaseAnnual Review of Biochemistry, 2011
- Membrane catalysis of peptide–receptor bindingThis paper is one of a selection of papers published in this special issue entitled “Canadian Society of Biochemistry, Molecular & Cellular Biology 52nd Annual Meeting — Protein Folding: Principles and Diseases” and has undergone the Journal's usual peer review process.Biochemistry and Cell Biology, 2010
- PLUMED: A portable plugin for free-energy calculations with molecular dynamicsComputer Physics Communications, 2009
- Targeted proteomic strategy for clinical biomarker discoveryMolecular Oncology, 2008
- Protein modulation of lipids, and vice-versa, in membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- Torsion angle dynamics for NMR structure calculation with the new program DyanaJournal of Molecular Biology, 1997
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- A novel myelin-associated glycoprotein defined by a mouse monoclonal antibodyJournal of Neuroimmunology, 1984